reference/5882005

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5882005

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	346
issn	0169-5002
issueIdentifier	3
pageRange	340-346
publicationName	Lung cancer (Amsterdam, Netherlands)
startingPage	340
bibliographicCitation	Treat J, Edelman MJ, Belani CP, Socinski MA, Monberg MJ, Chen R, Obasaju CK; Alpha Oncology Research Network. A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. Lung Cancer. 2010 Dec;70(3):340–6. doi: 10.1016/j.lungcan.2010.02.011. PMID: 20347506.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b912d3578ed8aa7196426fca0fcc0ebb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fed05587b06d3e680b58cfa92e69b86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f77e499ba492d4ae4b0b41f28b87a073 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe5d36bc1bb2579b16a796d8901e23ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_722eb783c7b2ff58d5cbc9378ff13e23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2024c5b9609dd8d6491986edcc11c6a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df289184812c5e969a084f269a5a4e4a
date	201012
identifier	https://pubmed.ncbi.nlm.nih.gov/20347506 https://doi.org/10.1016/j.lungcan.2010.02.011
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8534 https://portal.issn.org/resource/ISSN/0169-5002
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0024707 http://id.nlm.nih.gov/mesh/M000754277
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D000971
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D008175Q000503 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002289Q000503 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016190Q000008 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D000369
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 63.